pargyline has been researched along with Hyperprolactinemia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koike, K | 1 |
| Miyake, A | 1 |
| Aono, T | 1 |
| Sakumoto, T | 1 |
| Ohmichi, M | 1 |
| Yamaguchi, M | 1 |
| Tanizawa, O | 1 |
1 other study available for pargyline and Hyperprolactinemia
| Article | Year |
|---|---|
Effect of prolactin on the secretion of hypothalamic GnRH and pituitary gonadotropins.
Topics: Animals; Calcimycin; Calcium; Catecholamines; Dopamine; Dose-Response Relationship, Drug; Female; Fo | 1991 |